Tag: global 3D printed drugs market

Global 3D Printed Drugs Market Key Players Outlook, Latest Trends and Forecast up to 2025

The global 3D printed drugs market was valued at USD 214.3 million in 2017, and is projected to reach USD 295.5 million by 2025, growing at a CAGR of 4.2% during 2018–2025.

Major factors propelling the market growth for 3D printed drugs include technological innovations in 3D printing procedures, user-friendly and easy availability. Moreover, the ability to print drugs on-demand could reduce cost, increase the choice available to clinicians, reduce the risk of counterfeiting, and help personalize drug delivery to the needs of individual patients.

Based on technology type, Fused Deposition Modelling technology is anticipated to lead the market during 2018-2025

Fused Deposition Modelling is expected to hold the largest share in the market during the forecast period due to innovations and technological advancement in the field of pharmaceutical drugs. Inkjet Printer technology type is predicted to exhibit a high growth rate during the forecast period owing to surging adoption among patients due to its characteristics, such as producing 3D Drugs tablets at a constant rate and technologically advanced properties.

Key market players are investing a lot in the research & development activities. The companies are focusing on partnerships for developing 3D printed drugs.

Request for Sample Report https://www.gmiresearch.com/report/global-3d-printed-drugs-market-by-technique-type/sample-request

The research report global 3D Printed Drugs market provides an in-depth analysis of the 3D printed drugs market, globally, based on technology type and major geographies for the forecast period from 2018 to 2025. The report highlights the major market drivers propelling the growth as well as challenges faced by the market participants. The research report provides market size and forecast for 3D drugs market. The report also analyses the competitive landscape, major players and their strategies in 2018. The competitive landscape section of the report captures and highlights the recent developments in the market.

Request for Customization – https://www.gmiresearch.com/report/global-3d-printed-drugs-market-by-technique-type/request-for-customization

Key questions answered in this research report:
1. At what pace is the 3D printed drugs market growing worldwide? What will be the growth trend in the future?
2. What are the key drivers and restraints in the current market? What will be the impact of drivers and restraints in the coming years?
3. What are the regional revenue and forecast breakdowns? Which are the major regional revenue pockets for growth in the global 3D printed drugs market?
4. What are the various application areas and how they are poised to grow?

For Additional Insights, Click to Access Complete Report –  https://www.gmiresearch.com/report/global-3d-printed-drugs-market-by-technique-type//

About GMI Research

GMI Research is a market research and consulting firm which provides research-based solutions to business executives and investment professionals so that they can make right business & investment decisions faster based on real facts. We help business leaders through independent fact-based insight, ensuring their business achieve success by beating the competition. GMI Research’s leadership team with extensive experience in research and consulting together with our research and domain expertise creates a strong value proposition to create solutions that addresses our client’s business problems and add significant value to long lasting relationship.

The company provides syndicated research report, customized research, sales enablement research, data analytics and KPO (knowledge process outsourcing) service for Electronics & Semiconductors, Information Communication and Technology, Energy & Power, Healthcare, Automotive, Transportation & Logistics and Chemical industries. Our analysts and consultants who are passionate about research and consulting are recruited from renowned local and global universities and have worked with the leading local and international organizations.

Contact Us

Company Name: GMI RESEARCH

Contact Person: Sarah Nash

Email: enquiry@gmiresearch.com

Phone: +353 1 442 8820

Address:Level 1, The Chase Carmanhall Road, Sandyford Industrial Estate

City: Dublin

State: Dublin

Country: Ireland

Website: http://www.gmiresearch.com

Global 3D Printed Drugs Market exhibited a value of USD 214.3 million in 2017

Global 3D Printed Drugs Market exhibited a value of USD 214.3 million in 2017

Inkjet Printing technique to proliferate in the global 3D Drugs market and is expected to witness a high growth during the forecast period (2018-2025) owing to technological advantage and rising awareness about the drug – GMI Research

The global 3D printed drugs market exhibited a value of USD 214.3 million in 2017 and is projected to reach USD 295.7 million by 2025, growing at a CAGR of 4.2% during 2018–2025. The key factors boosting the market growth are the technological innovations in 3D printing procedures, the instant solubility of the drug in the mouth, and a rising number of epilepsy patients. Furthermore, increasing adoption of new generation 3D printing technology, growing incidence of epilepsy, rising technological advancement and spending on research and development by the top pharmaceutical companies like GlaxoSmithKline across have led to the burgeoning market growth of 3D printed drug market.

Download Sample Brochure : https://tinyurl.com/y8jranmk

Fused deposition modeling segment is expected to dominate the global 3D printed drugs market during the forecast period. In 2017, more than half of the market share was held by the fused deposition modeling technique. However, the inkjet printing technique type is expected to witness the fastest growth rate in the coming years because of growing adoption among healthcare professionals and patients due to extreme advancement in technology.

Increasing research & development coupled with technological advancement in the pharmaceutical drug are likely to spur the growth of the global 3D printed drugs market in near future.

“To tackle the deadly diseases pharmaceutical companies along with the 3D printing technology players are investing a lot in research and development of the 3D printed drugs. For instance, recently HP partnered with the Centers for Disease Control (CDC) for developing 3D printed drugs for the US’s deadly disease “Superbugs”. Every year around 2.0 million people in the US get directly infected with these superbugs and about 23.0 thousand people die due to the improper medical treatment. It is foreseen that personalized drugs will propel the growth of the 3D printed drugs market by 2025 “
—-GMI Research 

In 2017, North America held the largest share in the market on the back of increased adoption of technology, large volume epilepsy of patients and innovation in 3D drug technology and procedures. In addition, there has been a rise in the incidence of epilepsy disease. Europe has been amongst the growing regions for healthcare 3D printed drugs market and is predicted to grow at a moderate rate during the forecast period.

Buy Report Now @ https://tinyurl.com/y8jranmk

Key takeaways:
•    In 2017, more than half of the market share was held by the fused deposition modeling technique.
•    Apprecia Pharmaceuticals, GlaxoSmithKline and FabRx Ltd, and Hewlett Packard are the leading players holding approximately around one-third of the market share.
•    The inkjet printer product type is anticipated to grow at the highest rate during the forecast period from 2018 to 2025.
•    In 2017, North America held the largest share in the 3D printed drugs market.

Some of the key players operating in the global 3D printed drugs market include 3D Printer Drug Machine, Aprecia Pharmaceuticals, FabRx Ltd, GlaxoSmithKline Plc., Hewlett Packard Caribe, BV, National University of Singapore, The University of Nottingham, UCL School of Pharmacy, University College of London, University of Glasgow and others.

The global 3D printed drugs market has been segmented on the basis of technique type and key geographies. Based on technique type, the global 3D drugs market comprises of fused deposition modeling, inkjet printers, and others also including key geographical areas.

The research report on 3D drugs market provides an in-depth analysis of the global 3D printed drugs market, based on technique type and major geographies for the forecast period from 2018 to 2025. The report highlights the major market drivers propelling the growth as well as challenges faced by the market participants. The research report also provides market size and forecast for 3D printed drug market. The report also analyses the competitive landscape, major players and their strategies in 2018. The competitive landscape section of the report captures and highlights the recent developments in the market.

For more details, browse the Table of Contents: https://www.gmiresearch.com/report/global-3d-printed-drugs-market-opportunities-forecast-share-technology-type-insights-company-profile.html


Contact

Sarah Nash
Level 1, The Chase Carmanhall Road,
Sandyford Industrial Estate,
Dublin D18 Y3X2, Ireland
U.S Office +1 860 881 2270
Europe Office +353 1 442 8820
Email: enquiry@gmiresearch.com